Ozempic (semaglutide) causes digestive side effects in a significant number of users, with nausea, vomiting, diarrhea, abdominal pain, and constipation each affecting at least 5% of patients in clinical trials. Most of these are mild to moderate and fade within the first few weeks of treatment. But there are also less common, more serious risks worth understanding before you start or while you’re on the medication.
Digestive Side Effects Are the Most Common
The side effects you’re most likely to experience on Ozempic are all related to your gut: nausea, vomiting, diarrhea, stomach pain, and constipation. These happen because the drug slows down how fast your stomach empties food into your small intestine. That’s actually part of how it works. By keeping food in your stomach longer, Ozempic helps you feel full and reduces blood sugar spikes after meals. But a slower stomach also means food sits there longer than your body is used to, which can trigger nausea and discomfort.
The good news is that these symptoms are usually worst during the first four weeks of treatment and tend to fade as your body adjusts. Nausea in particular is typically mild to moderate and often disappears after the initial dose escalation phase, when you’re gradually stepping up from the starting dose. Some people never experience digestive side effects at all.
A few practical strategies can help. Eating smaller, more frequent meals reduces the volume of food your stomach has to process at once. Avoiding high-fat, fried, and very sugary foods also makes a difference, since those are the hardest for your body to digest while on a GLP-1 medication. Staying well hydrated is especially important if you’re dealing with vomiting or diarrhea, because dehydration from these symptoms can lead to more serious problems (more on that below).
How Dosing Affects Side Effects
Ozempic is prescribed using a gradual dose escalation schedule specifically designed to minimize side effects. You start at a low dose for four weeks, then your prescriber increases it as needed. This ramp-up gives your digestive system time to adapt. Side effects that appear during one dose level often settle down before you move to the next. If they don’t, your prescriber may hold you at a lower dose for longer before increasing.
Many of the digestive side effects don’t require medical attention and resolve on their own during treatment as your body adjusts to the medication.
Gastroparesis: When Slow Digestion Becomes a Problem
Because Ozempic intentionally slows stomach emptying, there’s a related but more serious concern: gastroparesis, a condition where the stomach empties far too slowly or essentially stops moving food forward. A study published in BMJ Open Gastroenterology found that people treated with semaglutide had a gastroparesis rate of 6.5 per 1,000 person-years, compared to 2.1 per 1,000 person-years for people on a different weight loss medication and 1.1 per 1,000 person-years for those who had sleeve gastrectomy surgery. After adjusting for other health differences between the groups, semaglutide users had roughly three times the risk.
Gastroparesis can cause persistent nausea, vomiting, bloating, and a feeling of fullness long after eating. It’s not the same as the temporary nausea most people get in the first few weeks. If your digestive symptoms are severe, getting worse instead of better, or lasting well beyond the dose adjustment period, that’s worth flagging to your prescriber.
Muscle Loss During Weight Loss
This side effect doesn’t show up on a standard list of symptoms, but it matters. When you lose weight on Ozempic, you don’t just lose fat. Data from the STEP-1 clinical trial showed that out of an average 15.3 kg (about 34 pounds) of total weight lost, roughly 6.9 kg (about 15 pounds) was lean mass, which includes muscle. That means about 45% of the weight lost came from lean tissue rather than fat.
That ratio raised concern among researchers because typical weight loss, regardless of method, usually follows what’s called the “quarter fat-free mass rule,” where about 25% of weight lost comes from lean tissue. The proportion seen with semaglutide was nearly double that expected amount. Losing muscle mass can affect your strength, metabolism, and long-term physical function, particularly for older adults. Resistance training and adequate protein intake during treatment are the primary ways to counteract this.
Kidney Injury Linked to Dehydration
Ozempic doesn’t directly damage your kidneys, but there’s an indirect pathway that can lead to acute kidney injury. When the drug’s digestive side effects cause significant vomiting or diarrhea, the resulting fluid loss can dehydrate you enough to stress your kidneys. This is most likely to happen during the early weeks of treatment or after a dose increase, when GI symptoms tend to be strongest.
Signs of kidney trouble include swelling in your legs or feet, changes in how much you urinate, or unusually dark urine. If you’re having persistent vomiting or diarrhea, staying on top of your fluid intake is critical. Prescribers will sometimes check kidney function with lab work if GI symptoms are severe, and they may pause or stop the medication if kidney function declines.
Pancreatitis Risk
Pancreatitis, or inflammation of the pancreas, has been a concern with GLP-1 medications as a class. In practice, the risk appears very low. A propensity score-matched analysis of type 2 diabetes patients in the United States found that the rate of pancreatitis was 0.1% in both those taking GLP-1 medications and those who were not. Still, it remains listed as a potential risk. Symptoms of acute pancreatitis include severe pain in the upper abdomen that may radiate to your back, often accompanied by nausea and vomiting. This type of pain is distinct from the mild stomach discomfort that’s common with Ozempic.
The Thyroid Cancer Warning
Ozempic carries the FDA’s most serious type of warning, a boxed warning, related to thyroid tumors. In animal studies, semaglutide caused a type of thyroid cancer called medullary thyroid carcinoma (MTC) in rodents. It hasn’t been confirmed whether this risk applies to humans, but the warning exists as a precaution. Ozempic is contraindicated for anyone with a personal or family history of MTC or a condition called Multiple Endocrine Neoplasia syndrome type 2.
Symptoms to be aware of include a lump or mass in your neck, difficulty swallowing, shortness of breath, or persistent hoarseness. These are uncommon, but they warrant prompt medical evaluation.
Eye Complications in People With Diabetes
For people taking Ozempic to manage type 2 diabetes, there’s a nuanced concern about diabetic retinopathy, a condition where high blood sugar damages blood vessels in the eye. In the SUSTAIN-6 clinical trial, semaglutide users had a 76% higher rate of diabetic retinopathy complications compared to the placebo group. Researchers believe this may be related to how quickly blood sugar drops rather than a direct toxic effect on the eyes. Rapid improvements in blood sugar control have been linked to temporary worsening of retinopathy with other diabetes treatments as well.
A larger real-world study of over 810,000 semaglutide users did not find an increased risk when comparing semaglutide to other diabetes medications. A separate analysis did find a modest increase in the rate of retinopathy requiring treatment, about 23% higher during semaglutide exposure. If you have existing diabetic eye disease, your prescriber will likely want to monitor your eyes more closely after starting treatment, especially during the period when blood sugar is dropping most rapidly.